Shelf‐Stable Human‐Derived Granular Extracellular Matrix (gECM) Hydrogel Wafers as 2.5D Substrates for Microphysiological Modeling
Advanced Healthcare Materials · 07.11.2026
DOI: 10.1002/adhm.71916 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 07.11.2026. Verfasst von Juliet O Heye und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mechanical Engineering, University of Colorado Boulder, Boulder, Colorado, USA. Die Arbeit nennt 73 Literaturangaben. Gefördert von: NIH HHS, National Science Foundation, National Institutes of Health.
Abstract (Originalsprache)
Understanding disease pathology and evaluating emerging therapeutics require in vitro models that accurately recapitulate human tissue environments. However, existing microphysiological systems often compromise either biomimicry or ease‐of‐use, limiting widespread adoption and scalability. Here, we present lyophilized granular extracellular matrix (gECM) hydrogel wafers as shelf‐stable, humanized 2.5D substrates that enable physiologically relevant modeling while simplifying integration into experimental workflows. Derived from decellularized human cartilage and bone, our gECM hydrogel wafers retain tissue‐specific architecture while introducing microporosity and surface topography through lyophilization. These wafers maintain swelling behavior, structural integrity, and mechanical properties over three months of room‐temperature storage, allowing pre‐fabrication and on‐demand use without loss of function. gECM hydrogel wafers support direct cell seeding without encapsulation and sustain viability and proliferation of human adipose‐derived mesenchymal stromal cells over 21 days. Furthermore, wafers can be readily integrated into proof‐of‐concept on‐chip fabrication with in situ hydration and transport of large biomolecules. Together, this platform bridges the gap between conventional 2D culture ease‐of‐use and 3D biomaterial biomimicry, providing a scalable, physiologically‐relevant, and humanized in vitro model approach that shows potential for future high‐throughput disease studies and therapeutic screening.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Mechanical Engineering, University of Colorado Boulder, Boulder, Colorado, USA.
- Biomedical Engineering Program, University of Colorado Boulder, Boulder, Colorado, USA.
- AlloSource, Centennial, Colorado, USA.
- KaomX, Saint-Étienne, France.
- Mines Saint-Étienne, Université Jean Monnet, INSERM, U1059 SaInBioSE, Saint-Étienne, France.
- BioFrontiers Institute, University of Colorado Boulder, Boulder, Colorado, USA.
ORCID-Profile: Juliet O Heye, Jeanne E Barthold, Stéphane Avril, Corey P Neu
Förderung
- NIH HHS
- National Science Foundation
- National Institutes of Health
Zitieren
APA
Heye, J. O., Blanco, S. A., Schneider, S. E., Gallegos, S., Barthold, J. E., Floren, M., Acosta, V., Avril, S., & Neu, C. P. (2026). Shelf‐Stable Human‐Derived Granular Extracellular Matrix (gECM) Hydrogel Wafers as 2.5D Substrates for Microphysiological Modeling. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71916
Vancouver
Heye JO, Blanco SA, Schneider SE, Gallegos S, Barthold JE, Floren M, et al. Shelf‐Stable Human‐Derived Granular Extracellular Matrix (gECM) Hydrogel Wafers as 2.5D Substrates for Microphysiological Modeling. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71916
BibTeX
@article{Heye2026,
author = {Heye, Juliet O and Blanco, Shannon A and Schneider, Stephanie E and Gallegos, Shantae and Barthold, Jeanne E and Floren, Michael and Acosta, Victor and Avril, Stéphane and Neu, Corey P},
title = {Shelf‐Stable Human‐Derived Granular Extracellular Matrix (gECM) Hydrogel Wafers as 2.5D Substrates for Microphysiological Modeling},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.71916}
}
EUVIMED